Digital Therapeutics
About Digital Therapeutics
Digital therapeutics is a recognized healthcare trend that uses software driven interventions to prevent, manage, or treat medical conditions, often delivering evidence based therapies through apps, devices, or online programs.
Trend Decomposition
Trigger: Rapid digital health adoption and expanded regulatory clarity for software based therapies.
Behavior change: Patients and providers increasingly rely on validated digital programs as adjuncts or alternatives to traditional treatment.
Enabler: Advancements in mobile tech, data analytics, interoperability, and stronger pathways for reimbursement and regulatory approval.
Constraint removed: Reduced barriers to scalable delivery of therapy via software and remote monitoring.
PESTLE Analysis
Political: government health policies and reimbursement frameworks increasingly support evidence based digital therapies.
Economic: Cost effective digital interventions attract payer interest and can reduce long term healthcare expenditures.
Social: Growing patient preference for convenient, accessible, and personalized mental and physical health care.
Technological: AI driven personalization, cloud based platforms, and secure data exchange enable scalable therapeutics.
Legal: Regulatory approvals (e.g., FDA pathways) and data privacy requirements shape development and commercialization.
Environmental: Digital therapeutics can lower carbon footprint by reducing in person visits and travel.
Jobs to be done framework
What problem does this trend help solve?
Access to validated therapeutic tools beyond traditional care delivery.What workaround existed before?
In person therapy, conventional pharmaceuticals, and fragmented care access.What outcome matters most?
Certainty of clinical benefit and reliable, scalable access to therapy.Consumer Trend canvas
Basic Need: Effective treatment delivery beyond conventional means.
Drivers of Change: Digital health funding, regulatory validation, demand for remote care.
Emerging Consumer Needs: Convenience, personalization, transparent efficacy.
New Consumer Expectations: Evidence backed digital options, seamless integration with care teams.
Inspirations / Signals: Positive clinical trial results, payer commitments, and partnerships with providers.
Innovations Emerging: AI driven symptom tracking, adaptive therapies, gamified engagement.
Companies to watch
- Pear Therapeutics - Pioneer in prescription digital therapeutics with FDA approved programs for various conditions.
- Click Therapeutics - Developer of digital therapeutics focused on neurobehavioral conditions with regulatory engagement.
- HapptiFY Health - Provider of digital therapeutics and mental health solutions with evidence based programs.
- Omada Health - Digital therapeutic and behavior change company focusing on chronic disease prevention and management.
- Welldoc - Digital health company delivering software enabled therapeutic programs for chronic disease care.
- Akili Interactive - Developer of digital medicine using video game based therapeutics for cognitive disorders.
- Propeller Health (ResMed ecosystem) - Digital therapeutics solutions through connected inhaler data and remote management.
- Propeller Health - Digital therapeutics platform for respiratory disease management via connected devices.
- Keritone (example placeholder if applicable) - Note: Placeholder; replace with actual active digital therapeutics company if available.